Magenta Therapeutics
Why Robinhood?
You can watch MGTA and buy or sell other stocks, ETFs, and their options commission-free!About MGTA
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies.
MGTA Key Statistics
Stock Snapshot
The current Magenta Therapeutics(MGTA) stock price is $11.99, with a market capitalization of 654.45M. The stock trades at a price-to-earnings (P/E) ratio of -20.82.
On 2026-05-13, Magenta Therapeutics(MGTA) stock opened at —, reached a high of —, and a low of —.
The Magenta Therapeutics(MGTA)'s current trading volume is 0, compared to an average daily volume of 472.2K.
During the past year, Magenta Therapeutics(MGTA) stock moved between $16.64 at its lowest and $96.50 at its peak.
During the past year, Magenta Therapeutics(MGTA) stock moved between $16.64 at its lowest and $96.50 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.